MLAB 005
Alternative Names: MLAB-005Latest Information Update: 10 Nov 2025
At a glance
- Originator MLAB Biosciences
- Class Biological proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 10 Nov 2025 Preclinical trials in Unspecified in USA (Parenteral) (MLAB Biosciences pipeline, November 2025)